E. , EASL clinical practice guidelines: liver transplantation, J Hepatol, vol.64, pp.433-85, 2016.

, ELTR report

, Clinical Practice EASL Guidelines on the management of acute (fulminant) liver failure, J Hepatol, vol.66, pp.1047-81, 2017.

R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim et al., Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, vol.124, issue.1, pp.91-97, 2003.
DOI : 10.1053/gast.2003.50016

W. Kim, S. Biggins, W. Kremers, R. Wiesner, P. Kamath et al., Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List, New England Journal of Medicine, vol.359, issue.10, pp.1018-1044, 2008.
DOI : 10.1056/NEJMoa0801209

M. Leise, W. Kim, W. Kremers, J. Larson, J. Benson et al., A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation, Gastroenterology, vol.140, issue.7, pp.1952-60, 2011.
DOI : 10.1053/j.gastro.2011.02.017

P. Northup, N. Intagliata, N. Shah, S. Pelletier, C. Berg et al., Excess mortality on the liver transplant waiting list: Unintended policy consequences and model for End-Stage Liver Disease (MELD) inflation, Hepatology, vol.13, issue.Suppl 1, pp.285-91, 2015.
DOI : 10.1002/lt.21155

H. Petrowsky, R. A. Kaldas, F. Sharma, A. Hong, J. Agopian et al., Liver Transplantation in Highest Acuity Recipients, Annals of Surgery, vol.259, issue.6, pp.1186-94, 2014.
DOI : 10.1097/SLA.0000000000000265

P. Mathurin, C. Moreno, D. Samuel, J. Dumortier, J. Salleron et al., Early Liver Transplantation for Severe Alcoholic Hepatitis, New England Journal of Medicine, vol.365, issue.19, pp.1790-800, 2011.
DOI : 10.1056/NEJMoa1105703

T. Gustot, J. Fernandez, E. Garcia, F. Morando, P. Caraceni et al., Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, vol.38, issue.Suppl 2, pp.243-52, 2015.
DOI : 10.1097/CCM.0b013e3181e71530

P. Sharma, D. Schaubel, Q. Gong, M. Guidinguer, and R. Merion, End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates, Hepatology, vol.45, issue.1, pp.192-200, 2012.
DOI : 10.1002/hep.21503

F. Artru, A. Louvet, I. Ruiz, E. Levesque, J. Labreuche et al., Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3, Journal of Hepatology, vol.67, issue.4, pp.708-723, 2017.
DOI : 10.1016/j.jhep.2017.06.009

URL : https://hal.archives-ouvertes.fr/hal-01760472

M. Nadim, J. Dinorcia, J. L. Groshen, S. Levistsky, J. Sung et al., Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease, Journal of Hepatology, vol.67, issue.3, pp.517-542, 2017.
DOI : 10.1016/j.jhep.2017.04.022

D. Weil, E. Levesque, M. Mcphall, R. Cavalazzi, E. Theocaridou et al., Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis, Annals of Intensive Care, vol.315, issue.424, p.33, 2017.
DOI : 10.1001/jama.2016.0288

URL : https://hal.archives-ouvertes.fr/hal-01519870

J. Lai, K. Covinsky, C. Mcculloch, and S. Feng, The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis, The American Journal of Gastroenterology, vol.5, issue.2, pp.235-277, 2018.
DOI : 10.1177/0898264312438551

P. Dutkowski, M. Linecker, M. Deoliveira, B. Mullhaupt, and P. Clavien, Challenges to Liver Transplantation and Strategies to Improve Outcomes, Gastroenterology, vol.148, issue.2, pp.307-330, 2015.
DOI : 10.1053/j.gastro.2014.08.045

E. Levesque, E. Hoti, D. Azoulay, P. Ichaï, H. Habouchi et al., Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an Intensive Care Unit, Journal of Hepatology, vol.56, issue.1, pp.95-102, 2012.
DOI : 10.1016/j.jhep.2011.06.024

F. Saliba, P. Ichaï, E. Levesque, and D. Samuel, Cirrhotic patients in the ICU, Current Opinion in Critical Care, vol.19, issue.2, pp.154-60, 2013.
DOI : 10.1097/MCC.0b013e32835f0c17

E. Levesque, F. Saliba, P. Ichaï, and D. Samuel, Outcome of patients with cirrhosis requiring mechanical ventilation in ICU, Journal of Hepatology, vol.60, issue.3, pp.570-578, 2014.
DOI : 10.1016/j.jhep.2013.11.012

D. Felmlee, A. Coilly, R. Chung, D. Samuel, and T. Baumert, New perspectives for preventing hepatitis C virus liver graft infection, The Lancet Infectious Diseases, vol.16, issue.6, pp.735-780, 2016.
DOI : 10.1016/S1473-3099(16)00120-1

L. Belli, M. Berenguer, P. Cortesi, M. Strazzabosco, S. Rockenschaub et al., Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study, Journal of Hepatology, vol.65, issue.3, pp.524-555, 2016.
DOI : 10.1016/j.jhep.2016.05.010

URL : https://hal.archives-ouvertes.fr/hal-01868079

M. Manns, D. Samuel, E. Gane, D. Mutimer, G. Mccaughan et al., Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial, The Lancet Infectious Diseases, vol.16, issue.6, pp.685-97, 2016.
DOI : 10.1016/S1473-3099(16)00052-9

M. Debette-gratien, T. Tabouret, M. Antonini, F. Dalmay, P. Carrier et al., Personalized Adapted Physical Activity Before Liver Transplantation, Transplantation, vol.99, issue.1, pp.145-50, 2015.
DOI : 10.1097/TP.0000000000000245

C. Duvoux, F. Roudot-thoraval, and T. Decaens, Liver Transplantation for Hepatocellular Carcinoma: A Model Including ??-Fetoprotein Improves the Performance of Milan Criteria, Gastroenterology, vol.143, issue.4, pp.986-94, 2012.
DOI : 10.1053/j.gastro.2012.05.052

URL : https://hal.archives-ouvertes.fr/inserm-00865368

E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel et al., Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor, American Journal of Transplantation, vol.6, issue.2 Suppl 1, pp.129-166, 2010.
DOI : 10.1111/j.1600-6143.2006.01509.x

V. Mazzaferro, E. Regalia, and R. Doci, Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, New England Journal of Medicine, vol.334, issue.11, pp.693-702, 1996.
DOI : 10.1056/NEJM199603143341104

F. Yao, L. Ferrell, and N. Bass, Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival, Hepatology, vol.33, issue.6, pp.1394-403, 2001.
DOI : 10.1053/jhep.2001.24563

V. Mazzaferro, J. Llovet, and R. Miceli, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, The Lancet Oncology, vol.10, issue.1, pp.35-43, 2009.
DOI : 10.1016/S1470-2045(08)70284-5

G. Crespo, N. Trota, M. Londono, E. Mauro, C. Balielas et al., The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition, Journal of Hepatology, vol.69, issue.1, 2018.
DOI : 10.1016/j.jhep.2018.02.012

R. Wong, M. Aguilar, R. Cheung, R. Perumpail, S. Harrison et al., Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States, Gastroenterology, vol.148, issue.3, pp.547-55, 2015.
DOI : 10.1053/j.gastro.2014.11.039